Results 1 to 10 of about 3,684 (214)

The association of relapsing polychondritis and spondylarthritis – three case reports [PDF]

Romanian Journal of Rheumatology, 2023
Background. Relapsing polychondritis (RP) is characterized by recurrent episodes of progressive inflammation that lead to the destruction of cartilaginous structures.
Eleonora Alina Dragomir-Lica, Denisa Elena Moscalu, Luminita Enache, Claudiu Costinel Popescu, Catalin Codreanu   +4 more
doaj   +1 more source

Pro-Inflammatory Oral Microbiota in Juvenile Spondyloarthritis: A Pilot Study

Children, 2022
The role of the microbiota in the pathogenesis of arthritis is gaining increasing attention. While multiple studies have queried the intestinal microbiota, very few have analyzed the contents of the oral microbiota.
Matthew L Stoll, Jue Wang, Chung How Kau, Margaret Kathy Pierce, Casey D Morrow, Nicolaas C Geurs   +5 more
doaj   +1 more source

The Role of Gut Microbiome in Psoriatic Arthritis—A Literature Review

Physiologia, 2023
Psoriatic arthritis is a heterogeneous chronic autoimmune disorder characterized principally by skin lesions, arthritis, dactylitis and enthesitis.
Cristina Alexandru, Carmen Catalina Iorgus, Ionut Melesteu, Elena Daniela Șerban, Florin Bobircă, Maria Magdalena Constantin, Razvan Simu, Ioan Ancuța, Mihai Bojincă, Anca Bobircă   +9 more
doaj   +1 more source

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

Reumatismo, 2023
Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug’s ...
G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio   +8 more
doaj   +1 more source

Cardiovascular damage in seronegative spondylarthritis

One Health & Risk Management, 2022
Introduction. Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthritis (APs) 18-22% and in reactive
Mihaela STOICA, Anatolie SCORPAN, Oxana SARBU, Alexandru GOREA, Valeriu ISTRATI   +4 more
doaj   +3 more sources

THE SIGNATURE OF INTESTINAL DYSBIOSIS IN INFLAMMATORY RHEUMATIC DISEASES [PDF]

Romanian Journal of Rheumatology, 2019
The study of intestinal microbiota is an important and current subject. It is well known that the gut microbiota plays a decisive role in the development of intestinal function, contributes to the defense against different infections, gives tolerance to ...
Anca Cardoneanu, Alexandra Maria Burlui, Elena Rezus   +2 more
doaj   +1 more source

[Chronic back pain in axial spondylarthritis : Current diagnostic challenges and treatment possibilities].

, 2023
BACKGROUND Among chronic back diseases, axial spondylarthritis (axSpA) is the entity with the largest spectrum of specific anti-inflammatory treatment modalities; however, from a general medical perspective axSpA is only ranked as another etiology of ...
Möller, Burkhard
core   +1 more source

PULMONARY MANIFESTATIONS DURING SPONDYLARTHRITIS

, 2020
Introduction: Pleuropulmonary involvement in spondylarthritis has long been considered a rare and late manifestation of this group of diseases because of its asymptomatic nature and the failure of chest X-ray to detect early lung injury.
Tarik Youssoufi , Mehdi Boudhar , Fatima Zahra Haddani , Oulahri Soumia , Youssef El. Jebbouri , Abdelhafid Guich and Hasna Hassikou
core   +1 more source

Histocompatibility HLA class I in anterior uveitis patients with and without spondyloarthritis

Современная ревматология, 2018
Anterior uveitis (AU) and ankylosing spondylitis (AS) are associated with histocompatibility human leukocyte antigen (HLA)-B27. Previous genetic studies conducted in different populations have also demonstrated other genetic associations, including HLA ...
I. A. Guseva, A. A. Godzenko, I. Yu. Razumova   +2 more
doaj   +1 more source

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. [PDF]

, 2022
OBJECTIVES Many axial spondylarthritis (axSpA) patients receive a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) in combination with a tumour necrosis factor inhibitor (TNFi).
Santos, Maria Jose, Mann, H., Michelsen, B., Giuseppe, D. Di, Loft, A.G., Lindström, U., Mann, Herman, Ribeiro, Pedro Avila, Jacobsson, Lennart T. H.,, Ciurea, Adrian, van der Horst-Bruinsma, Irene, Geirsson, Árni J. n, Ionescu, Ruxandra, Nissen, Michael, Lindström, Ulf,, Loft, A. G., Tomsic, Matija, Askling, Johan, Tomsic, M., Relas, H., Hetland, Merete Lund, Sokka-Isler, Tuulikki, Michelsen, Brigitte, Jacobsson, L., Van der Horst-Bruinsma, I., Iannone, Florenzo, Glintborg, Bente, Codreanu, C., Akkoc, N., Yildirim Cetin, Gozde, Fagerli, K. M., Ribeiro, P. A., Ribeiro, P. Avila, Nekvindova, Lucie, Santos, M.J., Di Giuseppe, D., Cetin, G. Yildirim, Codreanu, Catalin, Pombo-Suarez, M., Conti, F., Ionescu, R., Möller, B., Cetin, G. Y., Santos, M. J., Delcoigne, B. nédicte, Jacobsson, Lennart, Delcoigne, B., Relas, Heikki, Loft, Anne Gitte, Pombo-Suarez, Manuel, Fagerli, K.M., Möller, Burkhard, Geirsson, A. J., Conti, Fabrizio, Avila Ribeiro, Pedro, Gudbjornsson, B., Nissen, M., Sanchez-Piedra, Carlos, Glintborg, B., Hetland, M.L., Lindstroem, Ulf, Geirsson, Árni Jón, Moeller, Burkhard, Akkoc, Nurullah, Iannone, F., Askling, J., Sanchez-Piedra, C., Di Giuseppe, Daniela, Horst-Bruinsma, I.E. van der, Rotar, Z., Á, J. Geirsson, Rotar, Ziga, Nekvindova, L., Delcoigne, Bénédicte, Fagerli, Karen Minde, Hetland, M. L., Sokka-Isler, T., Gudbjornsson, Bjorn, Lindström, Ulf, Cetin, Gozde Yildirim, Ciurea, A.   +80 more
core   +1 more source